NEW YORK, July 19 (GenomeWeb News) - Sigma-Aldrich has licensed a number of RNA interference patents known as the Kreutzer-Limmer patent family from Alnylam Pharmaceuticals to provide research products and services, the companies said today.
The patents cover short interfering RNAs and their use to mediate RNA interference in mammalian cells.
Including Sigma, 12 companies have taken licenses to Alnylam's patent estate so far, including seven reagent and service providers.